-
Targeting NUAK1/2 to Reduce Pathological Tau in Alzheimer’s
2026-06-26
Taylor et al. (2023) provide the first direct evidence that tau phosphorylated at serine 356 (p-tau Ser356) is closely associated with Alzheimer’s pathology in human brain tissue, and that selective NUAK1/2 inhibition by WZ4003 can lower this tau species ex vivo. These findings offer mechanistic insight into kinase-driven tau accumulation and highlight translational opportunities for therapeutic development in neurodegeneration.
-
Sulfaphenazole: Potent CYP2C9 Inhibitor for Vascular Researc
2026-06-26
Sulfaphenazole is a selective CYP2C9 inhibitor with proven efficacy in vascular endothelial function research and antibacterial applications. Peer-reviewed studies confirm its ability to restore endothelium-dependent vasodilation and reduce oxidative stress in diabetic animal models. The compound supports precise modulation of drug metabolism and offers a favorable safety profile for laboratory workflows.
-
Engineered Microneedles Enable Targeted TM Gene Delivery in
2026-06-25
This study introduces an annular sector-shaped microneedle patch for localized co-delivery of nicotinamide and Nmnat1 gene-loaded lipid nanoparticles to the trabecular meshwork, aiming to reverse mitochondrial dysfunction in glaucoma. The approach demonstrates enhanced gene and drug bioavailability, significant intraocular pressure reduction, and restoration of TM function, highlighting a new combinatorial platform for targeted ocular gene therapy.
-
Fluorene-9-Bisphenol Inhibits GPER: New Insights in Neurobla
2026-06-25
This study uncovers a novel mechanism by which fluorene-9-bisphenol (BHPF) acts as a G protein-coupled estrogen receptor (GPER) inhibitor, modulating apoptosis in human neuroblastoma cells. Through integrated computational and experimental approaches, the research provides evidence for direct GPER antagonism by BHPF, expanding the understanding of endocrine disruption and estrogen signaling in neurobiology.
-
Z-WEHD-FMK: Decoding Caspase Signaling in Inflammation Resea
2026-06-24
Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) empowers precise dissection of inflammatory caspase pathways in cell biology and infectious disease models. This guide translates cutting-edge reference findings and hands-on troubleshooting into actionable workflows for apoptosis and pyroptosis studies.
-
AP-1 Inhibition Induces Ferroptosis via PI3K/AKT in Myeloma
2026-06-23
This study demonstrates that T-5224, a selective C-Fos/AP-1 inhibitor, triggers ferroptosis in multiple myeloma cells by modulating the PI3K/AKT pathway. These findings introduce a new mechanism of cell death in myeloma, expanding the therapeutic potential of AP-1 inhibitors beyond established anti-inflammatory and apoptotic roles.
-
WSP-5 for Live-Cell Imaging: Workflow, Applications, and Tip
2026-06-23
WSP-5 (Washington State Probe-5) delivers rapid, ultra-sensitive fluorescent detection of hydrogen sulfide in live-cell and disease models, surpassing previous probes in speed and selectivity. Discover step-by-step protocols, advanced applications in disease modeling, and troubleshooting strategies that make WSP-5 an indispensable tool for H2S research.
-
UBC9 Regulates PINK1 SUMOylation and Mitophagy in Parkinson’
2026-06-22
The reference study uncovers how UBC9 enhances mitophagy and attenuates oxidative stress in Parkinson’s disease models by promoting the SUMOylation of PINK1 at specific lysine residues. These findings clarify a previously undefined neuroprotective mechanism, providing a foundation for novel therapeutic strategies targeting mitochondrial quality control in neurodegeneration.
-
Optimized hiPSC Platelet Differentiation: Protocols and Insi
2026-06-22
This study presents a systematically optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), addressing key barriers of cost, heterogeneity, and inefficiency. By integrating higher embryoid body cell counts, human platelet lysate supplementation, and small-molecule modulators, the approach advances scalable, cost-effective platelet production for translational research.
-
miR-18a/ALOXE3 Axis Regulates Ferroptosis and Migration in G
2026-06-21
This study uncovers a novel mechanism in glioblastoma where miR-18a promotes tumor progression by downregulating ALOXE3, thereby suppressing ferroptosis and enhancing cell migration. These findings provide new insights into the metabolic and redox vulnerabilities of GBM, suggesting therapeutic potential in targeting the miR-18a/ALOXE3 pathway.
-
MK 0893: Glucagon Receptor Antagonist Workflows & Solutions
2026-06-20
MK 0893 stands out as a best-in-class glucagon receptor antagonist, offering nanomolar potency and selectivity for translational diabetes research. This article delivers actionable workflows, protocol enhancements, and troubleshooting guidance to maximize MK 0893’s impact in cell-based and in vivo studies.
-
Substance P: Advanced Protocols and Signal Interference Solu
2026-06-19
Explore the multifaceted role of Substance P, a key tachykinin neuropeptide, in pain transmission and immune modulation research. This article uniquely integrates advanced assay parameters with state-of-the-art spectral interference solutions, offering deeper insights for CNS research.
-
Eltanexor (KPT-8602): Advancing XPO1 Inhibition in Oncology
2026-06-19
Eltanexor (KPT-8602) is redefining cancer research by targeting nuclear export mechanisms fundamental to tumor progression. This article offers translational researchers an integrated perspective on mechanistic insights, current evidence, and experimental guidance, framing Eltanexor as a next-generation tool for both hematologic and solid tumor studies.
-
Prestained Protein Marker: Triple Color Ladder for Precision
2026-06-18
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) empowers high-resolution SDS-PAGE and Western blot workflows with unmatched clarity and compatibility for advanced phosphoprotein analysis. Its vivid tri-color bands, EDTA-free formulation, and ready-to-use convenience remove barriers to reproducibility in both routine and cutting-edge proteomics.
-
Eltanexor Modulates Wnt/β-Catenin to Suppress Colorectal Tum
2026-06-18
The referenced study demonstrates that XPO1 inhibition by Eltanexor (KPT-8602) disrupts Wnt/β-catenin signaling, reducing tumor burden and COX-2 expression in colorectal cancer models. These findings provide mechanistic evidence for XPO1 as a chemopreventive target, highlighting Eltanexor's translational potential for high-risk colorectal cancer prevention.